Gangliosidosis, GM1 Completed Phase 2 Trials for Clofarabine (DB00631)

Also known as: GM1 Gangliosidosis / [X]Other gangliosidosis

IndicationStatusPhase
DBCOND0003891 (Gangliosidosis, GM1)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00383448HSCT for High Risk Inherited Inborn ErrorsTreatment